Staging neurodegenerative disorders: Structural, regional, biomarker, and functional progressions

Neurotoxicity Research

Volumn 19, Issue 2, 2011, Pages 211-234

  Archer, Trevor ^d   Kostrzewa, Richard M ^a   Beninger, Richard J ^b   Palomo, Tomas ^c  

^a East Tennessee State University   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d NONE

Author keywords

AD; Braak; CBD; DARSS intervention; Imaging PD; LBD; Staging; Viral infections MCI

Indexed keywords

ABC TRANSPORTER A1; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SYNUCLEIN; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GLYCOPROTEIN GP 130; INTERLEUKIN 6; LEVODOPA; PARKIN; QUINPIROLE; SPINOPHILIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DAILY LIFE ACTIVITY; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG MECHANISM; EPISODIC MEMORY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HERPES ZOSTER ENCEPHALITIS; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEMANTIC MEMORY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAGING;

ANIMALS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; NEURODEGENERATIVE DISEASES;

ANIMALIA;

EID: 79751534535     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9190-2     Document Type: Article

References (341)

1. D Aarsland CG Ballard G Halliday 2004 Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatr Neurol 17 137 145 10.1177/0891988704267470 (Pubitemid 39128223)
2. S Ahmed R Arnold SA Thompson KS Graham JR Hodges 2008 Names of objects, faces and buildings in mild cognitive impairment Cortex 44 746 752 18472044 10.1016/j.cortex.2007.02.002 (Pubitemid 351727860)
3. S Ahmed J Mitchell R Arnold PJ Nestor JR Hodges 2008 Predicting rapid clinical progression in amnestic mild cognitive impairment Dement Geriatr Cogn Disord 25 170 177 18212499 10.1159/000113014 (Pubitemid 351196130)
4. A Akram D Christoffel AB Rocher C Bouras E Kövari DP Perl JH Morrison FR Herrmann V Haroutunian P Giannakopoulos PR Hof 2008 Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease Neurobiol Aging 29 1296 1307 1:CAS:528:DC%2BD1cXoslCls7s%3D 17420070 10.1016/j.neurobiolaging. 2007.03.007 (Pubitemid 351970597)
5. A Akram J Schmeidler P Katsel PR Hof V Haroutunian 2010 Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus Brain Res 1318C 167 177 10.1016/j.brainres.2010. 01.006 1:CAS:528:DC%2BC3cXitlWksLY%3D
6. I Alafuzoff T Arzberger S Al-Sarraj I Bodi N Bogdanovic H Braak O Bugiani K Del-Tredici I Ferrer E Gelpi G Giaccone MB Graeber P Ince W Kamphorst A King P Korkolopoulou GG Kovács S Larionov D Meyronet C Monoranu P Parchi E Patsouris W Roggendorf D Seilhean F Tagliavini C Stadelmann N Streichenberger DR Thal SB Wharton H Kretzschmar 2008 Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium Brain Pathol 18 484 496 18371174
7. GE Alexander K Chen P Pietrini SI Rapoport EM Reiman 2002 Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease Am J Psychiatr 159 738 745 11986126 10.1176/appi.ajp.159.5.738 (Pubitemid 34465046)
8. S Alladi R Arnold J Mitchell PJ Nestor JR Hodges 2006 Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile Psychol Med 36 507 515 16426486 10.1017/S0033291705006744 (Pubitemid 43381003)
9. G Alves T Wentzel-Larsen D Aarsland JP Larsen 2005 Progression of motor impairment and disability in Parkinson disease: a population-based study Neurology 65 1436 1441 16275832 10.1212/01.wnl.0000183359.50822.f2 (Pubitemid 41552776)
10. C Amlie-Lefond B Jubelt 2009 Neurologic manifestations of varicella zoster virus infections Curr Neurol Neurosci Rep 9 430 434 19818229 10.1007/s11910-009-0064-z
11. Archer T, Fredriksson A (2010) Physical exercise attenuates MPTP-induced deficits in mice. Neurotoxicity Res (in press)
12. Archer T, Beninger RJ, Palomo T, Kostrzewa RM (2010a) Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotoxicity Res (in press)
13. Archer T, Johansson B, Fredriksson A (2010b) Exercise alleviates parkinsonism: clinical and laboratory evidence. Acta Neurol Scand (in press)
14. Baillieux H, De Smet HJ, Dobbeleir A, Paquier PF, De Deyn PP, Mariën P (2009) Cognitive and affective disturbances following focal cerebellar damage in adults: a neuropsychological and SPECT study. Cortex, 2009 Oct 1 PMID: 19853848
15. A Bakkour JC Morris BC Dickerson 2009 The cortical signature of prodromal AD: regional thinning predicts mild AD dementia Neurology 72 1048 1055 19109536 10.1212/01.wnl.0000340981.97664.2f
16. J Barnes JL Whitwell C Frost KA Josephs M Rossor NC Fox 2006 Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer's disease and frontotemporal lobar degeneration Arch Neurol 63 1434 1439 17030660 10.1001/archneur.63.10.1434 (Pubitemid 44547556)
17. JC Baron G Chetelat B Desgranges G Perchey B Landeau V de la Sayette F Eustache 2001 In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease Neuroimage 14 298 309 1:STN:280: DC%2BD3MvitVGmug%3D%3D 11467904 10.1006/nimg.2001.0848 (Pubitemid 32709545)
18. M Basso J Yang L Warren MG MacAvoy P Varma RA Bronen CH van Dyck 2006 Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease Psychiatr Res 146 251 261 10.1016/j.pscychresns.2006.01.007 (Pubitemid 43782725)
19. Bastin C, Kerrouche N, Lekeu F, Adam S, Guillaume B, Lemaire C, Aerts J, d'Ydewalle G, Collette F, Salmon E (2010) Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research. J Alzheimers Dis, 2010 Feb 17. PMID: 20164554
20. K Bayulkem G Lopez 2010 Nonmotor fluctuations in Parkinson's disease: clinical spectrum and classification J Neurol Sci 289 89 92 19747695 10.1016/j.jns.2009.08.022
21. TG Beach CL White III CL Hladik MN Sabbagh DJ Connor HA Shill LI Sue J Sasse J Bachalakuri J Henry-Watson H Akiyama CH Adler Arizona Parkinson's Disease Consortium 2009 Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders Acta Neuropathol 117 169 174 1:CAS:528:DC%2BD1MXhtVCltLg%3D 18982334 10.1007/s00401-008-0450-7
22. NC Berchtold CW Cotman 1998 Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s Neurobiol Aging 19 173 189 1:STN:280:DyaK1czisVeluw%3D%3D 9661992 10.1016/S0197-4580(98) 00052-9 (Pubitemid 128714320)
23. D Berg W Roggendorf U Schroder R Klein T Tatschner P Benz O Tucha M Preier KW Lange K Reiners M Gerlach G Becker 2002 Echogenecity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury Arch Neurol 59 999 1005 12056937 10.1001/archneur.59.6.999 (Pubitemid 34640761)
24. M Bisaglia S Mammi L Bubacco 2009 Structural insights on physiological functions and pathological effects of alpha-synuclein FASEB J 23 329 340 1:CAS:528:DC%2BD1MXhs1Kmtbs%3D 18948383 10.1096/fj.08-119784
25. A Bloch A Probst H Bissig H Adams M Tolnay 2006 Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathol Appl Neurobiol 32 284 295 1:CAS:528:DC%2BD28XlvVyju78%3D 16640647 10.1111/j.1365-2990.2006.00727.x
26. BF Boeve AE Lang I Litvan 2003 Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia Ann Neurol 54 Suppl 5 S15 S19 12833363 10.1002/ana.10570 (Pubitemid 36760148)
27. BF Boeve KA Josephs DA Drubach 2008 Current and future management of the corticobasal syndrome and corticobasal degeneration Handb Clin Neurol 89 533 548 18631775 10.1016/S0072-9752(07)01249-3
28. Bohnen NI, Albin RL (2010) The cholinergic system and Parkinson disease. Behav Brain Res, 2010 Jan 7 PMID: 20060022
29. RM Bonelli JL Cummings 2007 Frontal-subcortical dementias Neurologist 14 100 107 10.1097/NRL.0b013e31815b0de2 (Pubitemid 351366942)
30. C Bouras PR Hof JH Morrison 1993 Neurofibrillary tangle dendrites in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathological changes Neurosci Lett 153 131 135 1:STN:280:DyaK3szhslamsg%3D%3D 8327187 10.1016/0304-3940(93)90305-5 (Pubitemid 23147053)
31. P Bourgeat G Chételat VL Villemagne J Fripp P Raniga K Pike O Acosta C Szoeke S Ourselin D Ames KA Ellis RN Martins CL Masters CC Rowe O Salvado AIBL Research Group 2010 Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia Neurology 74 121 127 1:CAS:528:DC%2BC3cXjsFGk 20065247 10.1212/WNL.0b013e3181c918b5
32. H Braak E Braak 1991 Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 239 259 1:STN:280:DyaK387gtFOiug%3D%3D 1759558 10.1007/BF00308809
33. H Braak E Braak 1995 Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol Aging 16 271 278 1:STN:280: DyaK28%2FjsVynsg%3D%3D 7566337 10.1016/0197-4580(95)00021-6
34. H Braak E Braak 1997 Frequency of stages of Alzheimer-related lesions in different age categories Neurobiol Aging 18 351 357 1:STN:280: DyaK2svnt1Sgug%3D%3D 9330961 10.1016/S0197-4580(97)00056-0 (Pubitemid 27435070)
35. H Braak E Braak 2000 Pathoanatomy of Parkinson's disease J Neurol 247 3 10 10.1007/PL00007758 (Pubitemid 30224300)
36. H Braak K Del Tredici 2009 Neuroanatomy and pathology of sporadic Parkinson's disease Adv Anat Embryol Cell Biol 201 1 119 19230552
37. Braak H, Braak E, Yilmazer D, Schultz C, Devos RAI, Jansen ENH (1995) Nigral and extranigral pathology in Parkinson's disease. J Neural Transm (Suppl): 15-31 (Pubitemid 26043220)
38. H Braak E Braak D Yilmazer RA de Vos ENH Jansen J Bohl 1996 Pattern of brain destruction in Parkinson's and Alzheimer's disease J Neural Transm 103 455 490 1:STN:280:DyaK1c3nvVemsw%3D%3D 9617789 10.1007/BF01276421 (Pubitemid 26131746)
39. H Braak K Del Tredici U Rüb RA de Vos EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 12498954 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
40. H Braak U Rüb WP Gai K Del Tredici 2003 Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen J Neural Transm 110 517 536 1:STN:280:DC%2BD3s3gt1GltQ%3D%3D 12721813 10.1007/s00702-002-0808-2 (Pubitemid 36543283)
41. H Braak E Ghebremedhin U Rüb H Bratzke K Del Tredici 2004 Stages in the development of Parkinson's disease-related pathology Cell Tissue Res 318 121 134 15338272 10.1007/s00441-004-0956-9 (Pubitemid 39362633)
42. H Braak U Rüb EN Jansen Steur K Del Tredici RA de Vos 2005 Cognitive status correlates with neuropathologic stage in Parkinson disease Neurology 64 1404 1410 1:STN:280:DC%2BD2M3hsleruw%3D%3D 15851731 (Pubitemid 40570509)
43. H Braak I Alafuzoff T Arzberger H Kretzschmar K Del Tredici 2006 Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol 112 389 404 16906426 10.1007/s00401-006-0127-z (Pubitemid 44469160)
44. H Braak JR Bohl CM Müller U Rüb RA de Vos K Del Tredici 2006 Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered Mov Disord 21 2042 2051 17078043 10.1002/mds.21065 (Pubitemid 46140410)
45. H Braak CM Müller U Rüb H Ackermann H Bratzke RA de Vos K Tredici 2006 Pathology associated with sporadic Parkinson's disease-where does it end? J Neural Transm 70 89 97 10.1007/978-3-211-45295-0-15 (Pubitemid 44622184)
46. Braak H, Del Tredici K, Gai WP, Braak E (2009) Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system. J Chem Neuroanat 20:245-252
47. KM Bradley VT O'Sullivan NDW Soper Z Nagy EMF King AD Smith BJ Shepstone 2002 Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease Brain 125 1772 1781 1:STN:280:DC%2BD38zoslWqtw%3D%3D 12135968 10.1093/brain/awf185
48. AM Brickman SA Small A Fleisher 2009 Pinpointing synaptic loss caused by Alzheimer's disease with fMRI Behav Neurol 21 93 100 19847048
49. H Burianova AR McIntosh CL Grady 2010 A common functional brain network for autobiographical, episodic, and semantic memory retrieval Neuroimage 49 865 874 19744566 10.1016/j.neuroimage.2009.08.066
50. DJ Burn 2006 Cortical Lewy body disease and Parkinson's disease dementia Curr Opin Neurol 19 572 579 17102696 10.1097/01.wco.0000247607.34697.a2 (Pubitemid 44760441)
51. ALH Bush PA Allen KP Kaut PK Ogrocki 2007 Influence of mild cognitive impairment on visual word recognition Aging Neuropsychol Cogn 14 329 352 10.1080/13825580600630278 (Pubitemid 47027104)
52. NJ Cairns MD Ikonomovic T Benzinger M Storandt AM Fagan AR Shah LT Reinwald D Carter A Felton DM Holtzman MA Mintun WE Klunk JC Morris 2009 Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report Arch Neurol 66 1557 1562 10.1001/archneurol.2009.279
53. E Canu DG McLaren ME Fitzgerald BB Bendlin G Zoccatelli F Alessandrini FB Pizzini GK Ricciardi A Beltramello SC Johnson GB Frisoni 2010 Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease J Alzheimers Dis 19 963 976 20157252
54. NE Carlson MM Moore A Dame D Howieson LC Silbert JF Quinn JA Kaye 2008 Trajectories of brain loss in aging and the development of cognitive impairment Neurology 70 828 833 1:STN:280:DC%2BD1c7ntFemtw%3D%3D 18046010 10.1212/01.wnl.0000280577.43413.d9 (Pubitemid 351367518)
55. A Cedazo-Minguez B Winblad 2010 Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects Exp Gerontol 45 5 14 1:CAS:528:DC%2BD1MXhsFynt7nE 19796673 10.1016/j.exger.2009.09. 008
56. D Chan JC Janssen JL Whitwell HC Watt R Jenkins C Frost MN Rossor NC Fox 2003 Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study Lancet 362 1121 1122 14550701 10.1016/S0140-6736(03)14469-8 (Pubitemid 37222338)
57. G Chetelat B Desgranges V De La Sayette F Viader F Eustache JC Baron 2002 Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment NeuroReport 13 1939 1943 12395096 10.1097/00001756-200210280-00022 (Pubitemid 35398965)
58. G Chetelat B Desgranges V De La Sayette F Viader K Berkouk B Landeau C Lalevee F Le Doze B Dupuy D Hannequin JC Barn F Eustache 2003 Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment Brain 126 1955 1967 12821520 10.1093/brain/awg196 (Pubitemid 37059435)
59. G Chetelat B Desgranges V De La Sayette F Viader F Eustache JC Baron 2003 Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60 1374 1377 1:STN:280:DC%2BD3s7ovVKgug%3D%3D 12707450 (Pubitemid 36461002)
60. G Chetelat B Landeau F Eustache F Mézenge F Viader V de la Sayette B Desgranges JC Baron 2005 Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study Neuroimage 27 934 946 1:STN:280:DC%2BD2MvpvVahsw%3D%3D 15979341 10.1016/j.neuroimage.2005.05.015 (Pubitemid 41317262)
61. G Chételat F Eustache F Viader V De La Sayette A Pélerin F Mézenge D Hannequin B Dupuy JC Baron B Desgranges 2005 FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment Neurocase 11 14 25 15804920 10.1080/13554790490896938 (Pubitemid 40372856)
62. G Chételat M Fouquet G Kalpouzos I Denghien V De la Sayette F Viader F Mézenge B Landeau JC Baron F Eustache B Desgranges 2008 Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry Neuropsychologia 46 1721 1731 18289618 10.1016/j.neuropsychologia.2007.11.037
63. DO Claassen JE Parisi C Giannini BF Boeve DW Dickson KA Josephs 2008 Frontotemporal dementia mimicking dementia with Lewy bodies Cogn Behav Neurol 21 157 163 18797258 10.1097/WNN.0b013e3181864a09
64. PD Coleman DG Flood 1987 Neuron numbers and dendritic extent in normal aging and Alzheimer's disease Neurobiol Aging 8 521 545 1:STN:280: DyaL1c7it1yqtw%3D%3D 3323927 10.1016/0197-4580(87)90127-8 (Pubitemid 18006178)
65. C Colosimo AJ Hughes L Kilford AJ Lees 2003 Lewy body cortical involvement may not always predict dementia in Parkinson's disease J Neurol Neurosurg Psychiatr 74 852 856 1:STN:280:DC%2BD3s3otlOjsQ%3D%3D 12810766 10.1136/jnnp.74.7.852 (Pubitemid 36782982)
66. R Cools A Miyakawa M Sheridan M D'Esposito 2010 Enhanced frontal function in Parkinson's disease Brain 133 225 233 1:STN:280:DC%2BC3c%2FgsVOqtg%3D%3D 19995871 10.1093/brain/awp301
67. CW Cotman NC Berchtold 2002 Exercise: a behavioural intervention to enhance brain health and plasticity Trends Neurosci 25 295 301 1:CAS:528:DC%2BD38Xks1ymtL8%3D 12086747 10.1016/S0166-2236(02)02143-4 (Pubitemid 34667010)
68. LA Coward 2010 The hippocampal system as the cortical resource manager: a model connecting psychology, anatomy and physiology Adv Exp Med Biol 657 315 364 20020356 10.1007/978-0-387-79100-5-18
69. L Crews E Rockenstein E Masliah 2010 APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis Brain Struct Funct 214 111 126 1:CAS:528:DC%2BC3cXktVCnsbY%3D 20091183 10.1007/s00429-009-0232-6
70. Crivello F, Lemaître H, Dufouil C, Grassiot B, Delcroix N, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2010) Effects of ApoE-varepsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. Neuroimage, 2010 Jan 6 PMID: 20060049
71. Cronk BB, Johnson DK, Burns JM; the Alzheimer's Disease Neuroimaging Initiative (2009) Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord, 2009 Jun 30 PMID: 19571736
72. E Cubo PM Martín JA Martin-Gonzalez C Rodríguez- Blázquez J Kulisevsky ELEP Group Members 2010 Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease Mov Disord 25 70 75 20014110 10.1002/mds.23215
73. HJ De Smet H Baillieux P Wackenier M De Praeter S Engelborghs PF Paquier PP De Deyn P Mariën 2009 Long-term cognitive deficits following posterior fossa tumor resection: a neuropsychological and functional neuroimaging follow-up study Neuropsychology 23 694 704 19899828 10.1037/a0016106
74. K Del Tredisi U Rub RAI De Vos JRE Bohl H Braak 2002 Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61 413 426 (Pubitemid 34533671)
75. A Delacourt JP David N Sergeant L Buee A Wattez P Vermersch F Ghozali C Fallet-Bianco F Pasquier F Lebert H Petit C Di Menza 1999 The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease Neurology 52 1158 1165 (Pubitemid 29177915)
76. A Delacourte 2008 Tau, a biological marker of neurodegenerative diseases Handb Clin Neurol 89 161 172 18631741 10.1016/S0072-9752(07)01215-8
77. L DeToledo-Morrell TR Stoub RS Wilson DA Bennett S Leurgans J Wuu DA Turner 2004 MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD Neurobiol Aging 25 1197 1203 15312965 10.1016/j.neurobiolaging.2003. 12.007 (Pubitemid 39094022)
78. L deToledo-Morrell TR Stoub C Wang 2007 Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease Prog Brain Res 163 741 753 17765748 10.1016/S0079-6123(07)63040-4 (Pubitemid 47321461)
79. DP Devanand G Pradhaban X Liu A Khandji S De Santi S Segal H Rusinek GH Pelton LS Honig R Mayeux Y Stern MH Tabert MJ de Leon 2007 Hippocampal and entorhinal atrophy in mild cognitive atrophy: prediction of Alzheimer disease Neurology 68 828 836 1:STN:280:DC%2BD2s7ltlWktA%3D%3D 17353470 10.1212/01.wnl.0000256697.20968.d7 (Pubitemid 46568534)
80. CM Dhaenens S Schraen-Maschke H Tran V Vingtdeux D Ghanem O Leroy J Delplanque E Vanbrussel A Delacourte P Vermersch CA Maurage H Gruffat A Sergeant MS Mahadevan S Ishiura L Buée TA Cooper ML Caillet-Boudin N Charlet-Berguerand B Sablonnière N Sergeant 2008 Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats Exp Neurol 210 467 478 1:CAS:528:DC%2BD1cXksVKrsrc%3D 18177861 10.1016/j.expneurol.2007.11.020
81. M Di Paola E Macaluso GA Carlesimo F Tomaiuolo KJ Worsley L Fadda C Caltagirone 2007 Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study J Neurol 254 774 781 17404777 10.1007/s00415-006-0435-1 (Pubitemid 47012455)
82. SG Diamond CH Markham MM Hoehn FH McDowell MD Muenter 1989 Effect of age at onset on progression and mortality in Parkinson's disease Neurology 39 1187 1190 1:STN:280:DyaL1MzmsFGquw%3D%3D 2771070 (Pubitemid 19239721)
83. BC Dickerson H Eichenbaum 2010 The episodic memory system: neurocircuitry and disorders Neuropsychopharmacology 35 86 104 19776728 10.1038/npp.2009.126
84. BC Dickerson DH Salat JF Bates M Atiya RJ Killiany DN Greve AM Dale CE Stern D Blacker MS Albert RA Sperling 2004 Medial temporal lobe function and structure in mild cognitive impairment Ann Neurol 56 27 35 15236399 10.1002/ana.20163 (Pubitemid 38857357)
85. BC Dickerson DH Salat DN Greve EF Chua E Rand-Giovannetti DM Rentz L Bertram K Mullin RE Tanzi D Blacker MS Albert RA Sperling 2005 Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD Neurology 65 404 411 1:STN:280:DC%2BD2Mvit12jtg%3D%3D 16087905 10.1212/01.wnl.0000171450.97464.49 (Pubitemid 41099803)
86. BC Dickerson A Bakkour DH Salat E Feczko J Pacheco DN Greve F Grodstein CI Wright D Blacker HD Rosas RA Sperling A Atri JH Growdon BT Hyman JC Morris B Fischl RL Buckner 2009 The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals Cereb Cortex 19 497 510 18632739 10.1093/cercor/bhn113
87. DW Dickson H Uchikado H Fujishiro Y Tsuboi 2010 Evidence in favor of Braak staging of Parkinson's disease Mov Disord 25 S1 S78 S82 20187227 10.1002/mds.22637
88. R Duara DA Loewenstein MT Greig-Custo A Raj W Barker E Potter E Schofield B Small J Schinka Y Wu H Potter 2010 Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR Int J Geriatr Psychiatry 25 282 289 19565573 10.1002/gps.2334
89. RB Dudas F Clague SA Thompson KS Graham JR Hodges 2005 Episodic and semantic memory in mild cognitive impairment Neuropsychologia 43 1266 1276 1:STN:280:DC%2BD2MzgsVWqug%3D%3D 15949511 10.1016/j.neuropsychologia.2004.12.005 (Pubitemid 40798357)
90. A Duong V Whitehead K Hanratty H Chertkow 2006 The nature of lexico-semantic processing deficits in mild cognitive impairment Neuropsychologia 44 1928 1935 16616942 10.1016/j.neuropsychologia.2006.01.034 (Pubitemid 43927988)
91. I Dupiereux W Zorzi I Quadrio A Perret-Liaudet GG Kovacs E Heinen B Elmoualij 2009 Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy Cent Nerv Syst Agents Med Chem 9 2 11 1:CAS:528:DC%2BD1MXks1WjtLo%3D 20021333
92. Farina E, Baglio F, Caffarra P, Magnani G, Scarpini E, Appollonio I, Bascelli C, Cheldi A, Nemni R, Franceschi M; Italian Group for Lewy Body Dementia and Dementias Associated to Parkinsonism, Messa G, Mantovani F, Bellotti M, Olivotto F, Alberoni M, Isella V, Regazzoni R, Schiatti E, Vismara C, Falautano M, Barbieri A, Restelli I, Fetoni V, Donato M, Zuffi M, Castiglioni S (2009) Frequency and clinical features of Lewy body dementia in Italian memory clinics. Acta Biomed 80: 57-64
93. N Fayed J Dávila A Oliveros Jr J Medrano J Castillo 2010 Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment Neurol Res 32 157 165 1:CAS:528:DC%2BC3cXht1ertbzP 20158954 10.1179/174313209X405164
94. M Fouquet B Desgranges B Landeau E Duchesnay F Mezenge V de la Sayette F Viader JC Baron F Eustache G Chetelat 2009 Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease Brain 132 2058 2067 19477964 10.1093/brain/awp132
95. K Fujimi K Sasaki K Noda Y Wakisaka Y Tanizaki Y Matsui A Sekita M Iida Y Kiyohara S Kanba T Iwaki 2008 Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study Brain Pathol 18 125 317 10.1111/j.1750-3639.2008.00169.x (Pubitemid 351782854)
96. S Fujita M Kiguchi M Kobayashi N Koshikawa JL Waddington 2010 Involvement of NMDA receptors in the ventrolateral striatum of rats in apomorphine-induced jaw movements Brain Res 1322 30 37 1:CAS:528:DC%2BC3cXjt1WktLw%3D 20122906 10.1016/j.brainres.2010.01.068
97. Gadre G, Satishchandra P, Mahadevan A, Suja M, Madhusudana S, Sundaram C, Shankar S (2009) Rabies viral encephalitis-clinical determinants in diagnosis with special reference to paralytic form. J Neurol Neurosurg Psychiatry, 2009 Dec 3 PMID: 19965838
98. JE Galvin VM Lee JQ Trojanowski 2001 Synucleinopathies: clinical and pathological implications Arch Neurol 58 186 190 1:STN:280: DC%2BD3M7ntFWlsQ%3D%3D 11176955 10.1001/archneur.58.2.186 (Pubitemid 32163154)
99. JL George S Mok D Moses S Wilkins AI Bush RA Cherny DI Finkelstein 2009 Targeting the progression of Parkinson's disease Curr Neuropharmacol 7 9 36 1:CAS:528:DC%2BD1MXhtVWqsrbL 19721815 10.2174/157015909787602814
100. M Gerlach P Reiderer 1999 Time sequences of dopaminergic cell death in Parkinson's disease: indications for neuroprotective studies Adv Neurol 80 219 225 1:CAS:528:DC%2BD3cXotlA%3D 10410725
101. A Ginanneschi F Degl'Innocenti S Magnolfi MT Maurello L Catarzi P Marini L Amaducci 1988 Evaluation of Parkinson's disease: reliability of three rating scales Neuroepidemiology 7 38 41 1:STN:280:DyaL1c7it1yrug%3D%3D 3340268 10.1159/000110159 (Pubitemid 17165383)
102. A Ginanneschi F Degl'Innocenti MT Maurello S Magnolfi P Marini L Amaducci 1991 Evaluation of Parkinson's disease: a new approach to disability Neuroepidemiology 10 282 287 1:STN:280:DyaK387oslSjuw%3D%3D 1798431 10.1159/000110285
103. CG Goetz 2000 Nineteenth century studies of atypical parkinsonism: Charcot and his Salpetriére school Adv Neurol 82 1 8 1:STN:280: DC%2BD3c%2FovFGqsA%3D%3D 10624466
104. CG Goetz 2006 What's new? Clinical progression and staging of Parkinson's disease J Neural Transm 70 305 308 10.1007/978-3-211-45295-0-46 (Pubitemid 44622215)
105. CG Goetz W Poewe O Rascol C Sampaio GT Stebbins C Counsell N Giladi RG Holloway CG Moore GK Wenning MD Yahr L Seidl Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease 2004 Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations Mov Disord 19 1020 1028 15372591 10.1002/mds.20213 (Pubitemid 39302834)
106. Gold BT, Johnsrude IS, Jicha GA, Smith CD (2010) Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal aging. Hum Brain Mapp, 2010 Jan 8 PMID: 20063353
107. CD Good IS Johnsrude J Ashburner RN Henson KJ Friston RS Frackowiak 2001 A voxel-based morphometric study of ageing in 465 normal adult human brains Neuroimage 14 21 36 1:STN:280:DC%2BD3MvotFCntg%3D%3D 11525331 10.1006/nimg.2001.0786 (Pubitemid 32552740)
108. CD Good IS Johnsrude J Ashburner RN Henson KJ Friston RS Frackowiak 2001 Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains Neuroimage 14 685 700 1:STN:280:DC%2BD3Mvmt1Kjsw%3D%3D 11506541 10.1006/nimg.2001.0857 (Pubitemid 32801715)
109. LT Grinberg U Rüb RE Ferretti R Nitrini JM Farfel L Polichiso K Gierga W Jacob-Filho H Heinsen Brazilian Brain Bank Study Group 2009 The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 35 406 416 1:CAS:528:DC%2BD1MXpsFGgtbc%3D 19508444 10.1111/j.1365-2990.2008.00997.x
110. E Grober D Dickson MJ Sliwinski H Buschke M Katz H Crystal RB Lipton 1999 Memory and mental status correlates of modified Braak staging Neurobiol Aging 20 573 579 1:STN:280:DC%2BD3M%2FjtFOktA%3D%3D 10674422 10.1016/S0197-4580(99) 00063-9 (Pubitemid 30064402)
111. Gunn DG, Naismith SL, Lewis SJ (2010) Sleep disturbances in Parkinson's disease and their potential role in heterogeneity. J Geriatr Psychiatr Neurol, 2010 Jan 25 PMID: 20101072
112. Halliday GM, Del Tredici K, Braak H (2006) Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. J Neural Transm (Suppl 70): 99-103 (Pubitemid 44622185)
113. AJ Harding GM Halliday 2001 Cortical Lewy body pathology in the diagnosis of dementia Acta Neuropathol 102 355 363 1:CAS:528:DC%2BD3MXmsFWgs7w%3D 11603811 (Pubitemid 32894706)
114. V Haroutunian P Katsel J Schmeidler 2009 Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia Neurobiol Aging 30 561 573 1:CAS:528:DC%2BD1MXjtF2ns7k%3D 17845826 10.1016/j.neurobiolaging.2007.07.021
115. D Hassabis D Kumaran SD Vann EA Maguire 2007 Patients with hippocampal amnesia cannot imagine new experiences Proc Natl Acad Sci USA 104 1726 1731 1:CAS:528:DC%2BD2sXhslGisbk%3D 17229836 10.1073/pnas.0610561104 (Pubitemid 46214658)
116. A Hassan JL Whitwell BF Boeve CR Jack Jr JE Parisi DW Dickson KA Josephs 2010 Symmetric corticobasal degeneration (S-CBD) Parkinsonism Relat Disord 16 208 214 20018548 10.1016/j.parkreldis.2009.11.013
117. Hauser RA, Pahwa R, Lyons KE, McClain T (2009) Parkinson disease. Available at http://emedicine.medscape.com/article/1151267-overview
118. MW Hayes VS Fung TE Kimber JD O'Sullivan 2010 Current concepts in the management of Parkinson disease Med J Aust 192 144 149 20121682
119. SS Hébert K Horré L Nicolaï AS Papadopoulou W Mandemakers AN Silahtaroglu S Kauppinen A Delacourte B De Strooper 2008 Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression Proc Natl Acad Sci USA 105 6415 6420 18434550 10.1073/pnas.0710263105 (Pubitemid 351758360)
120. SS Hébert K Horré L Nicolaï B Bergmans AS Papadopoulou A Delacourte B De Strooper 2009 MicroRNA regulation of Alzheimer's amyloid precursor protein expression Neurobiol Dis 33 422 428 19110058 10.1016/j.nbd.2008.11.009 1:CAS:528:DC%2BD1MXitVSjtr4%3D
121. MM Hoehn 1992 The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras Neurol Clin 10 331 339 1:STN:280: DyaK383mtFGhsA%3D%3D 1584177
122. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
123. MM Hoehn MD Yahr 1998 Parkinsonism: onset, progression, and mortality. 1967 Neurology 50 318 344 9484345
124. Hoehn MM, Yahr MD (2001) Parkinsonism: onset, progression, and mortality. 1967. Neurology 57(10 Suppl 3): S11-S26
125. BL Holman KA Johnson B Gerada PA Carvalho A Satlin 1992 The scintigraphic appearance of Alzheimer's disease: a prospective study using tecnetium-99 m-HMPAO SPECT J Nucl Med 33 181 185 1:STN:280:DyaK387itF2mug%3D%3D 1732438
126. C Holmes D Cotterell 2009 Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment CNS Drugs 23 993 1002 1:CAS:528:DC%2BC3cXhtlahtrk%3D 19958038 10.2165/11310910-000000000-00000
127. KE Hoque RP Indorkar S Sammut AR West 2010 Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity Psychopharmacology 207 571 581 1:CAS:528:DC%2BD1MXhsVOgtLnE 19816675 10.1007/s00213-009-1687-0
128. O Hornykiewicz 1998 Biochemical aspects of Parkinson's disease Neurology 51 S2 S9 1:CAS:528:DyaK1cXlsFeit7Y%3D 9711973
129. WT Hu GW Rippon BF Boeve DS Knopman RC Petersen JE Parisi KA Josephs 2009 Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome Mov Disord 24 1375 1379 19425061 10.1002/mds.22574
130. JG Hunsberger SS Newton AH Bennett CH Duman DS Russell SR Salton RS Duman 2007 Antidepressant actions of the exercise-regulated gene VGF Nat Med 13 1476 1782 1:CAS:528:DC%2BD2sXhtl2gs7bJ 18059283 10.1038/nm1669 (Pubitemid 350224242)
131. HI Hurtig JQ Trojanowski J Galvin D Ewbank ML Schmidt VM Lee CM Clark G Glosser MB Stern SM Gollomp SE Arnold 2000 Alpha-synuclein cortical lewy bodies correlate with dementia in Parkinson's disease Neurology 54 1916 1921 1:STN:280:DC%2BD3c3osVWhug%3D%3D 10822429 (Pubitemid 30327112)
132. A Hurwitz 1989 The benefit of a home exercise regime for ambulatory Parkinson's disease patients J Neurosci Nurs 21 180 184 1:STN:280: DyaL1M3nvVyiuw%3D%3D 2525159 10.1097/01376517-198906000-00008
133. BT Hyman GW Van Hoesen AR Damasio CL Barnes 1984 Alzheimer's disease: cell-specific pathology isolates the hippocampal formation Science 225 1168 1170 1:STN:280:DyaL2czgtVejsg%3D%3D 6474172 10.1126/science.6474172 (Pubitemid 14029099)
134. PG Ince EK Perry CM Morris 1998 Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8 299 324 1:STN:280: DyaK1c3gs1eltw%3D%3D 9546289 10.1111/j.1750-3639.1998.tb00156.x (Pubitemid 28186068)
135. T Ishizawa P Mattlia P Davies D Wang DW Dickson 2003 Colocalization of tau and α-synuclein epitopes in Lewy bodies J Neuropathol Exp Neurol 62 389 397 1:CAS:528:DC%2BD3sXjt1yrsbc%3D 12722831 (Pubitemid 36403039)
136. M Iwakiri K Mizukami MD Ikonomovic M Ishikawa S Hidaka EE Abrahamson ST DeKosky T Asada 2005 Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging Acta Neuropathol 109 467 474 1:CAS:528:DC%2BD2MXltFGqt7o%3D 15759131 10.1007/s00401-005-0985-9 (Pubitemid 40909190)
137. K Iwanaga K Wakabayashi M Yoshimoto I Tomita H Satoh H Takashima A Satoh M Seto M Tsujihata H Tahahashi 1999 Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases Neurology 52 1269 1271 1:STN:280:DyaK1M3ivFGluw%3D%3D 10214756 (Pubitemid 29177934)
138. CR Jack Jr RC Petersen YC Xu SC Waring PC O'Brien EG Tangalos GE Smith RJ Ivnik E Kokmen 1997 Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease Neurology 49 786 794 9305341 (Pubitemid 27428023)
139. CR Jack Jr MM Shiung JL Gunter PC O'Brien SD Weigand DS Knopman BF Boeve RJ Ivnik GE Smith RH Cha EG Tangalos RC Petersen 2004 Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD Neurology 62 591 600 14981176 (Pubitemid 38252801)
140. CR Jack Jr SD Weigand MM Shiung SA Przybelski PC O'Brien JL Gunter DS Knopman BF Boeve GE Smith RC Petersen 2008 Atrophy rates accelerate in amnestic mild cognitive impairment Neurology 70 1740 1752 18032747 10.1212/01.wnl. 0000281688.77598.35 (Pubitemid 351653966)
141. CR Jack Jr VJ Lowe SD Weigand HJ Wiste ML Senjem DS Knopman MM Shiung JL Gunter BF Boeve BJ Kemp M Weiner RC Petersen Alzheimer's Disease Neuroimaging Initiative 2009 Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease Brain 132 1355 1365 19339253 10.1093/brain/awp062
142. CR Jack Jr DS Knopman WJ Jagust LM Shaw PS Aisen MW Weiner RC Petersen JQ Trojanowski 2010 Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 119 128 1:CAS:528:DC%2BC3cXhtFeru74%3D 20083042 10.1016/S1474-4422(09)70299-6
143. W Jagust R Thisted MD Devous R Van Heertum H Mayberg K Jobst AD Smith N Borys 2001 SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study Neurology 56 950 956 1:STN:280:DC%2BD3MzisV2lug%3D%3D 11294935 (Pubitemid 32290814)
144. AM Jauhiainen M Pihlajamaki S Tervo E Niskanen H Tanila T Hanninen RL Vanninen H Soininen 2009 Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment Hippocampus 19 166 175 18777563 10.1002/hipo.20494
145. V Jelic K Palmer B Winblad 2003 Mild cognitive impairment: unanswered questions and future directions Acta Neurol Scand Suppl 179 100 101 12603256 10.1034/j.1600-0404.107.s179.14.x (Pubitemid 41737342)
146. KA Jellinger 2003 α-Synuclein pathology in Parkinson and Alzheimer disease brain: incidence and topographic distribution-a pilot study Acta Neuropathol 106 191 201 12845452 10.1007/s00401-003-0725-y (Pubitemid 37021251)
147. KA Jellinger 2004 Lewy body-related α-synucleinopathy in the aged human brain J Neural Transm 111 1219 1235 1:CAS:528:DC%2BD2cXotFCrtbk%3D 15480835 10.1007/s00702-004-0138-7 (Pubitemid 39468387)
148. KA Jellinger 2008 A critical reappraisal of current staging of Lewy-related pathology in human brain Acta Neuropathol 116 1 16 1:CAS:528:DC%2BD1cXosVOjtbw%3D 18592254 10.1007/s00401-008-0406-y
149. KA Jellinger 2009 Formation and development of Lewy pathology: a critical update J Neurol 256 Suppl 3 S270 S279 10.1007/s00415-009-5243-y
150. KA Jellinger 2009 A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders Biochim Biophys Acta 1792 730 740 1:CAS:528:DC%2BD1MXnsFygs7k%3D 18718530
151. F Jessen L Feyen K Freymann R Tepest W Maier R Heun HH Schild L Scheef 2006 Volume reduction of the entorhinal cortex in subjective memory impairment Neurobiol Aging 27 1751 1756 16309795 10.1016/j.neurobiolaging.2005.10.010 (Pubitemid 44572584)
152. F Jessen O Gür W Block G Ende L Frölich T Hammen J Wiltfang T Kucinski H Jahn R Heun W Maier H Kölsch J Kornhuber F Träber 2009 A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI Neurology 72 1735 1740 1:STN:280:DC%2BD1MzlsVSjtA%3D%3D 19451528 10.1212/WNL. 0b013e3181a60a20
153. GA Jicha JE Parisi DW Dickson K Johnson R Cha RJ Ivnik EG Tangalos BF Boeve DS Knopman H Braak RC Petersen 2006 Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia Arch Neurol 63 674 681 16682537 10.1001/archneur.63.5.674
154. GA Jicha E Abner FA Schmitt GE Cooper N Stiles R Hamon S Carr CD Smith WR Markesberg 2008 Clinical features of mild cognitive impairment differ in the research and tertiary settings Dement Geriatr Cogn Disord 26 187 192 1:STN:280:DC%2BD1cngsVyqsg%3D%3D 18724049 10.1159/000151635
155. KA Jobst AD Smith CS Barker A Wear EM King A Smith PA Anslow AJ Molyneux BJ Shepstone N Soper 1992 Association of atrophy of medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease J Neurol Neurosurg Psychiatr 55 190 194 1:STN:280:DyaK383is1OmsQ%3D%3D 1564478 10.1136/jnnp.55.3. 190
156. EK Johns NA Phillips S Belleville D Goupil L Babins N Kelner B Ska B Gilbert G Inglis M Panisset C de Boysson H Chertkow 2009 Executive functions in frontotemporal dementia and Lewy body dementia Neuropsychology 23 765 777 19899835 10.1037/a0016792
157. KA Josephs JL Holton MN Rossor H Braendgaard T Ozawa NC Fox RC Petersen GS Pearl M Ganguly P Rosa H Laursen JE Parisi G Waldemar NP Quinn DW Dickson T Revesz 2003 Neurofilament inclusion body disease: a new proteinopathy? Brain 126 2291 2303 12876145 10.1093/brain/awg231 (Pubitemid 37432372)
158. KA Josephs RC Petersen DS Knopman BF Boeve JL Whitwell JR Duffy JE Parisi DW Dickson 2006 Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP Neurology 66 41 48 1:STN:280:DC%2BD28%2Fhs1Kgtg%3D%3D 16401843 10.1212/01.wnl.0000191307.69661.c3 (Pubitemid 43739589)
159. KA Josephs JE Ahlskog JE Parisi BF Boeve BA Crum C Giannini RC Petersen 2009 Rapidly progressive neurodegenerative dementias Arch Neurol 66 201 207 19204156 10.1001/archneurol.2008.534
160. ME Kalaitzakis MB Graeber SM Gentleman RK Pearce 2008 Controversies over the staging of α-synuclein pathology in Parkinson's disease Acta Neuropathol 116 125 128 18446352 10.1007/s00401-008-0381-3
161. ME Kalaitzakis MB Graeber SM Gentleman RK Pearce 2009 Parkinson disease: extranigral, multisystem, and {alpha}-synuclein "plus" Arch Neurol 66 914 915 19597100 10.1001/archneurol.2009.140
162. ME Kalaitzakis MB Graeber SM Gentleman RK Pearce 2009 Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's disease Neuropathol Appl Neurobiol 35 125 126 1:STN:280:DC%2BD1M7hsVGkuw%3D%3D 19187066 10.1111/j.1365-2990.2008.00998.x
163. G Kalpouzos G Chetelat B Landeau P Clochon F Viader F Eustache B Desgranges 2009 Structural and metabolic correlates of episodic memory in relation to the depth of encoding in normal aging J Cogn Neurosci 21 372 389 18510447 10.1162/jocn.2008.21027
164. T Kanazawa T Uchihara A Takahashi A Nakamura S Orimo H Mizusawa 2008 Three-layered structure shared between Lewy bodies and lewy neurites-three- dimensional reconstruction of triple-labeled sections Brain Pathol 18 415 422 18394008 10.1111/j.1750-3639.2008.00140.x (Pubitemid 351782850)
165. AW Kao CA Racine LC Quitania JH Kramer CW Christine BL Miller 2009 Cognitive and neuropsychiatric profile of the synnucleinopathies: Parkinson disease, dementia with lewy bodies, and multiple system atrophy Alzheimer Dis Assoc Disord 23 365 370 19935145 10.1097/WAD.0b013e3181b5065d
166. GB Karas P Scheltens SA Rombouts PJ Visser RA van Schijndel NC Fox F Barkhof 2004 Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease Neuroimage 23 708 716 1:STN:280:DC%2BD2crpsVKqsA%3D%3D 15488420 10.1016/j.neuroimage.2004.07.006 (Pubitemid 39370621)
167. O Katuse E Iseki W Marui K Kosaka 2003 Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with Dementia with Lewy bodies J Neurosci 211 29 35 (Pubitemid 36593264)
168. K Kawahara M Hashimoto P Bar-On GJ Ho L Crews H Mizuno E Rockenstein SZ Imam E Masliah 2008 alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease J Biol Chem 283 6979 6987 1:CAS:528:DC%2BD1cXivFyjtLw%3D 18195004 10.1074/jbc.M710418200
169. T Kawanabe A Yoritaka H Shimura H Oizumi S Tanaka N Hattori 2010 Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia Prog Neuropsychopharmacol Biol Psychiatr 34 284 287 10.1016/j.pnpbp.2009.11.019
170. Kemper TL (1994) Neuroanatomical and neuropathological changes during aging and in dementia. In: Albert ML, Knoepfel EJE (eds) Clinical neurology of aging, 2nd edn. Oxford University Press, New York, pp 3-67
171. RM Kostrzewa JP Kostrzewa R Brus 2003 Dopamine receptor supersensitivity: an outcome and index of neurotoxicity Neurotox Res 5 111 118 12832226 10.1007/BF03033376
172. RM Kostrzewa JP Kostrzewa RW Brown P Nowak R Brus 2008 Dopamine receptor sensitivity: development, mechanisms, presentation and clinical applicability Neurotox Res 14 121 128 1:CAS:528:DC%2BD1MXis1eks7s%3D 19073420 10.1007/BF03033804
173. Kostrzewa RM, Kostrzewa JP, Kostrzewa RA, Brus R, Nowak P (2010) Stereotypic progressions in psychotic behavior. Neurotoxicity Res (in press)
174. E Kövari G Gold FR Herrmann A Canuto PR Hof C Bouras P Giannakopoulos 2003 Lewy body densities in the entorhinal and anterior cingulated cortex predict cognitive deficits in Parkinson's disease Acta Neuropathol 106 83 88 12687392 (Pubitemid 36806171)
175. E Kövari G Gold FR Herrmann A Canuto PR Hof C Bouras P Giannakopoulos 2007 Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia Neurology 68 927 931 17372128 10.1212/01.wnl.0000257094.10655.9a (Pubitemid 46568505)
176. ML Kramer WJ Schulz-Schaeffer 2007 Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies J Neurosci 27 1405 1410 1:CAS:528:DC%2BD2sXhvFCrurg%3D 17287515 10.1523/JNEUROSCI.4564-06.2007
177. YD Kwak CL Brannen T Qu HM Kim X Dong P Soba A Majumdar A Kaplan K Beyreuther K Sugaya 2006 Amyloid precursor protein regulates differentiation of human neural stem cells Stem Cells Dev 15 381 389 1:CAS:528:DC%2BD28XmvFSlurw%3D 16846375 10.1089/scd.2006.15.381 (Pubitemid 44100015)
178. YD Kwak E Choumkina K Sugaya 2006 Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells Biochem Biophys Res Commun 344 431 437 1:CAS:528:DC%2BD28XjvFWnt7c%3D 16600175 10.1016/j.bbrc.2006.03.054
179. Kwak YD, Dantuma E, Merchant S, Bushnev S, Sugaya K (2010) Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway. Neurotoxicity Res, PMID: 20309664
180. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ; the Alzheimer's Disease Neuroimaging Initiative (2009) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging, 2009 Aug 4
181. AE Lang 2007 The progression of Parkinson disease: a hypothesis Neurology 68 948 952 17372132 10.1212/01.wnl.0000257110.91041.5d (Pubitemid 46568509)
182. Lang AE, Boeve BF, Bergeron C (2006) Corticobasal degeneration. In: Jankovic JJ, Tolosa E (eds) Parkinson's disease and movement disorders. Lippincott and Williams, Philadelphia, pp 186-202
183. JB Leverenz R Hamilton DW Tsuang A Schantz D Vavrek EB Larson WA Kukull O Lopez D Galasko E Masliah J Kaye R Woltjer C Clark JQ Trojanowski TJ Montine 2008 Empiric refinement of the pathologic assessment of lewy-related pathology in the dementia patient Brain Pathol 18 220 224 18241240 10.1111/j.1750-3639. 2007.00117.x (Pubitemid 351430400)
184. T Leyhe S Müller M Milian GW Eschweiler R Saur 2009 Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease Neuropsychologia 47 2464 2469 19409401 10.1016/j.neuropsychologia.2009.04.018
185. DD Lin JT Kleinman RJ Wityk RF Gottesman AE Hillis AW Lee PB Barker 2009 Crossed cerebellar diaschisis in acute stroke detected by dynamic susceptibility contrast MR perfusion imaging AJNR Am J Neuroradiol 30 710 715 1:STN:280:DC%2BD1M3mtlSkug%3D%3D 19193758 10.3174/ajnr.A1435
186. DA Loewenstein A Acevedo E Potter JA Schinka A Raj MT Greig J Agron WW Barker Y Wu B Small E Schofield R Duara 2009 Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests Am J Geriatr Psychiatry 17 1050 1058 20104061 10.1097/JGP.0b013e3181b7ef42
187. JA Lonie L Herrmann CL Donaghey K Ebmeier 2008 Clinical referral patterns and cognitive profile in mild cognitive impairment Br J Psychiatr 192 59 64 10.1192/bjp.bp.107.035642 (Pubitemid 351183162)
188. JA Lonie L Herrmann K Tierney CL Donaghey R O'Carroll K Ebmeier 2009 Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer's disease J Neuropsychol 3 79 92 19338718 10.1348/174866408X289935
189. Lonie JA, Kalu UG, Sexton CE, Mackay CE, Bastin M, Terriere E, O'Carroll RE, Ebmeier KP (2010) Mild cognitive impairment-a five year follow-up and imaging study. Neurotoxicity Res
190. JS Lou G Kearns B Oken G Sexton J Nutt 2001 Exacerbated physical fatigue and mental fatigue in Parkinson's disease Mov Disord 16 190 196 1:STN:280:DC%2BD3MvotlKgtg%3D%3D 11295769 10.1002/mds.1042 (Pubitemid 36049964)
191. E Luders C Gaser L Jancke G Schlaug 2004 A voxel-based approach to gray matter asymmetries Neuroimage 22 656 664 1:STN:280:DC%2BD2c3ptlKrsA%3D%3D 15193594 10.1016/j.neuroimage.2004.01.032 (Pubitemid 38759428)
192. E Lüders H Steinmetz L Jäncke 2002 Brain size and grey matter volume in the healthy human brain Neuroreport 13 2371 2374 12488829 10.1097/00001756-200212030-00040 (Pubitemid 36044461)
193. AB MacDonald 2007 Alzheimer's disease Braak Stage progressions: reexamined and redefined as Borrelia infection transmission through neural circuits Med Hypotheses 68 1059 1064 17113237 10.1016/j.mehy.2006.09.054 (Pubitemid 46274038)
194. AB MacDonald 2007 Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes Curr Microbiol 52 330 332
195. AB MacDonald JM Miranda 1987 Concurrent neocortical borreliosis and Alzheimer's disease Hum Pathol 18 759 761 1:STN:280:DyaL2s3kvVOgsA%3D%3D 3297997 10.1016/S0046-8177(87)80252-6 (Pubitemid 17124628)
196. EA Maguire DG Gadian IS Johnsrude CD Good J Ashburner RS Frackowiak CD Frith 2000 Navigation-related structural change in the hippocampi of taxi drivers Proc Natl Acad Sci USA 97 4398 4403 1:CAS:528:DC%2BD3cXislSnsL0%3D 10716738 10.1073/pnas.070039597 (Pubitemid 30226144)
197. EA Maguire R Nannery HJ Spiers 2006 Navigation around London by a taxi driver with bilateral hippocampal lesions Brain 129 2894 2907 17071921 10.1093/brain/awl286 (Pubitemid 44684511)
198. EA Maguire K Woollett HJ Spiers 2006 London taxi drivers and bus drivers: a structural MRI and neuropsychological analysis Hippocampus 16 1091 1101 17024677 10.1002/hipo.20233 (Pubitemid 46062833)
199. K Marek R Innis C van Dyck B Fussell M Early S Eberly D Oakes J Seibyl 2001 [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 2089 2094 1:STN:280:DC%2BD3MjgtFCrsA%3D%3D 11739831 (Pubitemid 33126879)
200. WR Markesbery 2010 Neuropathologic alterations in mild cognitive impairment: a review J Alzheimers Dis 19 221 228 20061641
201. WR Markesbery FA Schmitt RJ Kryscio DG Davis CD Smith DR Wekstein 2006 Neuropathologic substrate of mild cognitive impairment Arch Neurol 63 38 46 16401735 10.1001/archneur.63.1.38 (Pubitemid 43063860)
202. WR Markesbery GA Jicha H Liu FA Schmitt 2009 Lewy body pathology in normal elderly subjects J Neuropathol Exp Neurol 68 816 822 19535990 10.1097/NEN.0b013e3181ac10a7
203. WR Martin 2009 Quantitative estimation of regional brain iron with magnetic resonance imaging Parkinsonism Relat Disord 15 Suppl 3 S215 S218 20082994 10.1016/S1353-8020(09)70818-1
204. A Martorana F Mori Z Esposito H Kusayanagi F Monteleone C Codecà G Sancesario G Bernardi G Koch 2009 Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients Neuropsychopharmacology 34 2323 2328 1:CAS:528:DC%2BD1MXpvFygsbg%3D 19516251 10.1038/npp.2009.60
205. H Matsuda N Kitayama T Ohnishi T Asada S Nakano S Sakamoto E Imabayashi A Katoh 2002 Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease J Nucl Med 43 304 311 11884488 (Pubitemid 34208090)
206. PM Mattila JO Rinne H Helenius DW Dickson M Roytta 2000 Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease Acta Neuropathol 100 285 290 1:STN:280:DC%2BD3M%2FntVyitw%3D%3D 10965798 10.1007/s004019900168 (Pubitemid 30456155)
207. N Mattsson H Zetterberg O Hansson N Andreasen L Parnetti M Jonsson SK Herukka WM van der Flier MA Blankenstein M Ewers K Rich E Kaiser M Verbeek M Tsolaki E Mulugeta E Rosén D Aarsland PJ Visser J Schröder J Marcusson M de Leon H Hampel P Scheltens T Pirttilä A Wallin ME Jönhagen L Minthon B Winblad K Blennow 2009 CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 385 393 1:CAS:528:DC%2BD1MXptVCgu7Y%3D 19622817 10.1001/jama.2009.1064
208. K Meguro C LeMestric B Landeau B Desgranges F Eustache JC Baron 2001 Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study J Neurol Neurosurg Psychiatr 71 315 321 1:STN:280:DC%2BD3Mvms12htg%3D%3D 11511703 10.1136/jnnp.71.3.315 (Pubitemid 32772527)
209. D Merims M Freedman 2008 Cognitive and behavioural impairment in Parkinson's disease Int Rev Psychiatry 20 364 373 18925485 10.1080/ 09540260802095123
210. K Mevel B Desgranges JC Baron B Landeau V De la Sayette F Viader F Eustache G Chetelat 2007 Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches NeuroImage 37 18 25 17566762 10.1016/j.neuroimage.2007.04.048 (Pubitemid 47068990)
211. J Miklossy K Khalili L Gern RL Ericson P Darekar L Bolle J Hurlimann BJ Paster 2004 Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease J Alzheimers Dis 6 639 649 15665404 (Pubitemid 40164170)
212. S Minoshima B Giordani S Berent KA Frey NL Foster DE Kuhl 1997 Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 85 94 1:STN:280:DyaK2szmvFajsw%3D%3D 9225689 10.1002/ana.410420114 (Pubitemid 27304784)
213. K Mizuno M Wakai A Takeda G Sobue 2000 Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study J Neurol Sci 173 18 24 1:STN:280:DC%2BD3c7ktFCltw%3D%3D 10675575 10.1016/S0022-510X(99)00289-0 (Pubitemid 30081771)
214. H Mizusawa 1997 Corticobasal degeneration Rinsho Shinkeigaku 37 1131 1133 1:STN:280:DyaK1c3jvVGgsg%3D%3D 9577668 (Pubitemid 28189047)
215. J Moncrieff J Leo 2010 A systematic review of the effects of antipsychotic drugs on brain volume Psychol Med 20 1 14
216. E Mori Y Yoneda H Yamashita N Hirono M Ikeda A Yamadori 1997 Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study J Neurol Neurosurg Psychiatr 63 214 221 1:STN:280: DyaK2svivFyhsQ%3D%3D 9285461 10.1136/jnnp.63.2.214 (Pubitemid 27388972)
217. F Mori K Tanji H Zhang A Kakita H Takahashi K Wakabayashi 2008 Alpha-synuclein pathology in the neostriatum in Parkinson's disease Acta Neuropathol 115 453 459 1:CAS:528:DC%2BD1cXjsFGis7c%3D 18000672 10.1007/s00401-007-0316-4
218. JC Morris M Storandt JP Miller DW McKeel JL Price EH Rubin L Berg 2001 Mild cognitive impairment represents early-stage Alzheimer disease Arch Neurol 58 397 405 1:STN:280:DC%2BD3M7pvVCisA%3D%3D 11255443 10.1001/archneur.58.3.397 (Pubitemid 32217456)
219. JC Morris CM Roe EA Grant D Head M Storandt AM Goate AM Fagan DM Holtzman MA Mintun 2009 Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Arch Neurol 66 1469 1475 20008650 10.1001/archneurol.2009.269
220. L Mosconi 2005 Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD Eur J Nucl Med Mol Imaging 32 486 510 1:CAS:528:DC%2BD2MXjtV2hs7o%3D 15747152 10.1007/s00259-005-1762-7 (Pubitemid 40591181)
221. EB Mukaetova-Ladinska JH Xuereb F Garcia-Sierra J Hurt HJ Gertz R Hills C Brayne FA Huppert ES Paykel MA McGee R Jakes WG Honer CR Harrington CM Wischik 2009 Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe ScientificWorld J 9 1463 1475 1:CAS:528:DC%2BC3cXhtl2qtLo%3D
222. CM Müller RA de Vos CA Maurage DR Thal M Tolnay H Braak 2005 Staging of sporadic Parkinson disease-related α-synuclein pathology: inter- and intra-rater reliability J Neuropathol Exp Neurol 64 623 628 16042314 (Pubitemid 40995277)
223. Z Nagy NJ Hindley H Braak E Braak DM Yilmazer-Hanke C Schultz L Barnetson EM King KA Jobst AD Smith 1999 The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships Dement Geriatr Cogn Disord 10 115 120 1:STN:280: DyaK1M7lt1ehtw%3D%3D 10026385 10.1159/000017111 (Pubitemid 29099695)
224. Z Nagy NJ Hindley H Braak E Braak DM Yilmazer-Hanke C Schultz L Barnetson KA Jobst AD Smith 1999 Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study Dement Geriatr Cogn Disord 10 109 114 1:STN:280:DyaK1M7lt1ehtg%3D%3D 10026384 10.1159/000017110 (Pubitemid 29099694)
225. PT Nelson GA Jicha FA Schmitt H Liu DG Davis MS Mendiondo EL Abner WR Markesbery 2007 Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity J Neuropathol Exp Neurol 66 1136 1146 18090922 10.1097/nen.0b013e31815c5efb (Pubitemid 350294663)
226. PT Nelson H Braak WR Markesbery 2009 Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship J Neuropathol Exp Neurol 68 1 14 1:CAS:528:DC%2BD1MXhsFGlsrw%3D 19104448 10.1097/NEN.0b013e3181919a48
227. PT Nelson GA Jicha RJ Kryscio EL Abner FA Schmitt G Cooper LO Xu CD Smith WR Markesbery 2010 Low sensitivity in clinical diagnoses of dementia with Lewy bodies J Neurol 257 359 366 19795154 10.1007/s00415-009-5324-y
228. Nestor PJ, Scheltens P, Hodges JR (2004) Advances in the early detection of Alzheimer's disease. Nat Med 10(Supl): 534-541
229. A Nordberg JO Rinne A Kadir B Långström 2010 The use of PET in Alzheimer disease Nat Rev Neurol 6 78 87 1:CAS:528:DC%2BC3cXhs1Ogt7w%3D 20139997 10.1038/nrneurol.2009.217
230. P Nowak D Nitka A Kwieciński J Jośko J Drab D Pojda-Wilczek J Kasperski RM Kostrzewa R Brus 2009 Neonatal co-lesion by DSP-4 and 5, 7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists Pharmacol Rep 61 311 318 1:CAS:528:DC%2BD1MXhtl2ktrbO 19443944
231. P Nowak RA Kostrzewa D Skaba RM Kostrzewa 2010 Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats Neurotox Res 17 299 304 1:CAS:528:DC%2BC3cXjt1ajs7w%3D 19760476 10.1007/s12640-009-9105-2
232. GC O'Keeffe AW Mitchell RA Barker 2009 Biomerkers in Huntington's and Parkinson's disease Ann NY Acad Sci 1180 97 110 19906264 10.1111/j.1749-6632. 2009.04943.x
233. M Oguru H Tachibana K Toda B Okuda N Oka 2009 Apathy and depression in Parkinson disease J Geriatr Psychiatry Neurol 23 35 41 20015839 10.1177/0891988709351834
234. T Ohnishi H Matsuda T Tabira T Asada M Uno 2001 Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process AJNR Am J Neuroradiol 22 1680 1685 1:STN:280:DC%2BD3Mrms1KrsA%3D%3D 11673161 (Pubitemid 32999576)
235. Okazaki K, Fu YJ, Nishihira Y, Endo M, Fukushima T, Ikeuchi T, Okamoto K, Onodera O, Nishizawa M, Takahashi H (2009) Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology, 2009 Sep 22 PMID: 19780981
236. JM Olichney D Galasko DP Salmon CR Hofstetter LA Hansen R Katzman LJ Thal 1998 Cognitive decline is faster in Lewy body variant than in Alzheimer's disease Neurology 51 351 357 1:STN:280:DyaK1czntlOktA%3D%3D 9710002 (Pubitemid 28406305)
237. K Palmer AK Berger R Monastero B Winblad L Bäckman L Fratiglioni 2007 Predictors of progression from mild cognitive impairment to Alzheimer disease Neurology 68 1596 1602 1:STN:280:DC%2BD2s3nsFyhsw%3D%3D 17485646 10.1212/01.wnl.0000260968.92345.3f (Pubitemid 46717984)
238. K Palmer L Bäckman B Winblad L Fratiglioni 2008 Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease Am J Geriatr Psychiatry 16 603 611 18591580 10.1097/JGP.0b013e3181753a64
239. K Palmer L Bäckman B Winblad L Fratiglioni 2008 Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease Int Psychogeriatr 20 252 258 18257960 10.1017/S1041610207006564 (Pubitemid 351230233)
240. Parker-Pope T (2001) For a healthy brain you really need to use your head-physical and mental exercise can stave off mental decline. Wall St J Eur, November 26, 2001, 8
241. L Parkkinen H Soininen M Laakso I Alafuzoff 2001 Alpha-synuclein pathology is highly dependent on the case selection Neuropathol Appl Neurobiol 27 314 325 1:STN:280:DC%2BD3MvovFehuw%3D%3D 11532162 10.1046/j.0305-1846.2001. 00342.x (Pubitemid 32758618)
242. L Parkkinen H Soininen I Alafuzoff 2003 Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease J Neuropathol Exp Neurol 62 363 367 1:CAS:528:DC%2BD3sXjt1yrsbk%3D 12722828 (Pubitemid 36403036)
243. L Parkkinen T Kauppinen T Pirttila JM Autere I Alafuzoff 2005 Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia Ann Neurol 57 82 91 1:CAS:528:DC%2BD2MXpsFSktQ%3D%3D 15562510 10.1002/ana.20321 (Pubitemid 40053318)
244. L Parkkinen T Pirttila I Alafuzoff 2008 Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance Acta Neuropathol 115 399 407 18297293 10.1007/s00401-008-0346-6
245. RC Pearson MM Esiri RW Hiorns GK Wilcock TP Powell 1985 Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease Proc Natl Acad Sci USA 82 4531 4534 1:STN:280: DyaL2M3kt1Oiuw%3D%3D 3859874 10.1073/pnas.82.13.4531 (Pubitemid 15233154)
246. C Pennanen C Testa MP Laakso M Hallikainen EL Helkala T Hänninen M Kivipelto M Könönen A Nissinen S Tervo M Vanhanen R Vanninen GB Frisoni H Soininen 2005 A voxel based morphometry study on mild cognitive impairment J Neurol Neurosurg Psychiatry 76 11 14 1:STN:280: DC%2BD2cnjt1Gmuw%3D%3D 15607988 10.1136/jnnp.2004.035600 (Pubitemid 40013484)
247. C Pennanen C Testa M Boccardi MP Laakso M Hallikainen EL Helkala T Hänninen M Kivipelto M Könönen A Nissinen S Tervo M Vanhanen R Vanninen GB Frisoni H Soininen 2006 The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study Dement Geriatr Cogn Disord 22 60 66 16682795 10.1159/000093263
248. AC Pereira W Wu SA Small 2007 Imaging-guided microarray: isolating molecular profiles that dissociate Alzheimer's disease from normal aging Ann N Y Acad Sci 1097 225 238 17413025 10.1196/annals.1379.005 (Pubitemid 47084882)
249. RC Petersen JC Morris 2005 Mild cognitive impairment as a clinical entity and treatment target Arch Neurol 62 1160 1163 16009779 10.1001/archneur.62.7. 1160 (Pubitemid 41043744)
250. RC Petersen GE Smith SC Waring RJ Ivnik EG Tangalos E Kokmen 1999 Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 303 308 1:STN:280:DyaK1M3gsFSqtw%3D%3D 10190820 10.1001/archneur.56.3.303 (Pubitemid 29120227)
251. RC Petersen JE Parisi DW Dickson KA Johnson DS Knopman BF Boeve GA Jicha RJ Ivnik GE Smith EG Tangalos H Braak E Kokmen 2006 Neuropathologic features of amnestic mild cognitive impairment Arch Neurol 63 665 672 16682536 10.1001/archneur.63.5.665
252. RC Petersen PS Aisen LA Beckett MC Donohue AC Gamst DJ Harvey CR Jack Jr WJ Jagust LM Shaw AW Toga JQ Trojanowski MW Weiner 2010 Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 201 209 20042704 10.1212/WNL.0b013e3181cb3e25
253. GM Petracca RE Jorge L Acion D Weintraub RG Robinson 2009 Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease J Neuropsychiatr Clin Neurosci 21 406 412
254. Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M, Geroldi C, Ganzola R, Frisoni GB, Filippi M (2010) Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp, 2010 Feb 16 PMID: 20162601
255. Pihlajamäki M, O'keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RA (2010) Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease. Alzheimer Dis Assoc Disord 24:28-36
256. S Prabhu H Sripathi S Gupta M Prabhu 2009 Childhood herpes zoster: a clustering of ten cases Indian J Dermatol 54 62 64 20049274 10.4103/0019-5154. 48991
257. JL Price 1993 The relationship between tangle and plaque formation during healthy aging and mild dementia Neurobiol Aging 14 661 663 1:STN:280: DyaK2c7is1WgsQ%3D%3D 8295678 10.1016/0197-4580(93)90062-G (Pubitemid 23347911)
258. H Przuntek 1992 Early diagnosis in Parkinson's disease J Neural Transm 38 Suppl 105 114 1:STN:280:DyaK3s7kslyitA%3D%3D (Pubitemid 23026849)
259. Przuntek H, Müller T (eds) (1999) Diagnosis and treatment in Parkinson's disease-state of the art. Springer, Wien, New York
260. H Przuntek T Müller P Reiderer 2004 Diagnostic staging of Parkinson's disease: conceptual aspects J Neural Transm 111 201 216 1:STN:280:DC%2BD2c%2Fms1SisA%3D%3D 14767723 10.1007/s00702-003-0102-y (Pubitemid 38283231)
261. Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT (2010) The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology, 2010 Feb 15 PMID: 20167227
262. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A (2009) Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging, 2009 Dec 24 PMID: 20031276
263. Raz N (1996) Neuroanatomy of aging brain: evidence from structural MRI. In: Bigler ED (ed) Neuroimaging II: clinical application. Plenum Press, New York, pp 273-300
264. N Raz FM Gunning D Head JH Dupuis J McQuain SD Briggs WJ Loken AE Thornton JD Acker 1997 Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal grey matter Cereb Cortex 7 268 282 1:STN:280:DyaK2s3ovVClug%3D%3D 9143446 10.1093/cercor/7.3.268 (Pubitemid 27184486)
265. JJ Rebeiz EH Kolodny EP Richardson Jr 1968 Corticodentatonigral degeneration with neuronal achromasia Arch Neurol 18 20 33 1:STN:280: DyaF1c%2FkvV2rtA%3D%3D 5634369
266. P Reiderer P Foley 2002 Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism J Neural Transm 109 1469 1475 10.1007/s007020200095 (Pubitemid 36057056)
267. C Reitz AM Brickman TR Brown J Manly C DeCarli SA Small R Mayeux 2009 Linking hippocampal structure and function to memory performance in an aging population Arch Neurol 66 1385 1392 19901171 10.1001/archneurol.2009.214
268. F Remy F Mirrashed B Campbell W Richter 2005 Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study NeuroImage 25 253 266 15734360 10.1016/j.neuroimage.2004.10.045 (Pubitemid 40289153)
269. Resnick SM, Sojkova J, Zhou Y, An Y, Ye W, Holt DP, Dannals RF, Mathis CA, Klunk WE, Ferrucci L, Kraut MA, Wong DF (2010) Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 24:807-815
270. P Riekkinen UK Rinne TT Pelliniemi V Sonninen 1975 Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients Arch Neurol 32 25 27 1:STN:280:DyaE2M7gvVCkug%3D%3D 1115656
271. AC Rosen MW Prull JD Gabrieli T Stoub R O'Hara L Friedman JA Yesavage L de Toledo-Morrell 2003 Differential associations between entorhinal and hippocampal volumes and memory performance in older adults Behav Neurosci 117 1150 1160 14674836 10.1037/0735-7044.117.6.1150 (Pubitemid 37549418)
272. AC Rosen JD Gabrieli T Stoub MW Prull R O'Hara J Yesavage L de Toledo-Morrell 2005 Relating medial temporal lobe volume to frontal fMRI activation for memory encoding in older adults Cortex 41 595 602 16042035 10.1016/S0010-9452(08)70199-0 (Pubitemid 40932322)
273. Sánchez-Benavides G, Gómez-Ansón B, Molinuevo JL, Blesa R, Monte GC, Buschke H, Peña-Casanova J (2009) Medial temporal lobe correlates of memory screening measures in normal ageing, MCI, and AD. J Geriatr Psychiatry Neurol, 2009 Dec 30 PMID: 20029056
274. Schmahmann JD, Pandya DN (2006) Fiber pathways of the brain. Oxford University Press, New York
275. S Schnaudigel C Preul T Ugur HJ Mentzel OW Witte M Tittgemeyer G Hagemann 2010 Positional brain deformation visualized with magnetic resonance morphometry Neurosurgery 66 376 384 20087139 10.1227/01.NEU.0000363704.74450.B4
276. MJ Schnell JP McGettigan C Wirblich A Papaneri 2010 The cell biology of rabies virus: using stealth to reach the brain Nat Rev Microbiol 8 51 61 1:CAS:528:DC%2BD1MXhsVylsLnM 19946287
277. LM Shulman AL Gruber-Baldini KE Anderson PS Fishman SG Reich WJ Weiner 2010 The clinically important difference on the unified Parkinson's disease rating scale Arch Neurol 67 64 70 20065131 10.1001/archneurol.2009.295
278. G Simic G Stanic M Mladinov N Jovanov-Milosevic I Kostovic PR Hof 2009 Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 35 532 554 1:CAS:528:DC%2BD1MXhs1Wisr7K 19682326 10.1111/j.1365-2990.2009.01038.x
279. Sironi F, Trotta L, Antonini A, Zini M, Ciccone R, Della Mina E, Meucci N, Sacilotto G, Primignani P, Brambilla T, Coviello DA, Pezzoli G, Goldwurm S (2010) alpha-Synuclein multiplication analysis in Italian familial Parkinson disease. Parkinsonism Relat Disord 16:228-231
280. SA Small 2005 Alzheimer disease, in living color Nat Neurosci 8 404 405 1:CAS:528:DC%2BD2MXis1OrtLo%3D 15795742 10.1038/nn0405-404 (Pubitemid 41007551)
281. CD Smith 2007 Mild cognition impairment is too late: the case for presymptomatic detection and treatment for Alzheimer's disease Cogn Sci 3 127 177
282. CD Smith AH Andersen RJ Kryscio FA Schmitt MS Kindy LX Blonder JM Avison 1999 Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease Neurology 53 1391 1396 1:STN:280:DC%2BD3c%2FgtFyjtQ%3D%3D 10534240 (Pubitemid 29491926)
283. CD Smith H Chebrolu DR Wekstein FA Schmitt GA Jicha G Cooper WR Markesbery 2007 Brain structural alterations before mild cognitive impairment Neurology 68 1268 1273 1:STN:280:DC%2BD2s3ivFCitA%3D%3D 17438217 10.1212/01.wnl.0000259542.54830.34 (Pubitemid 46625972)
284. JA Sonnen EB Larson PK Crane S Haneuse G Li GD Schellenberg S Craft JB Leverenz TJ Montine 2007 Pathological correlates of dementia in a longitudinal, population-based sample of aging Ann Neurol 62 406 413 17879383 10.1002/ana.21208 (Pubitemid 350105954)
285. JA Sonnen KS Montine JF Quinn JA Kaye JC Breitner TJ Montine 2008 Biomarkers for cognitive impairment and dementia in elderly people Lancet Neurol 7 704 714 1:CAS:528:DC%2BD1cXhtVSku73E 18635019 10.1016/S1474-4422(08)70162-5 (Pubitemid 351965506)
286. JA Sonnen KS Montine JF Quinn JC Breitner TJ Montine 2010 Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia J Alzheimers Dis 19 301 309 20061646
287. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, Laviolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA (2010) Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 12:27-43
288. HJ Spiers EA Maguire 2006 Spontaneous mentalizing during an interactive real world task: an fMRI study Neuropsychologia 44 1674 1682 16687157 10.1016/j.neuropsychologia.2006.03.028 (Pubitemid 43928014)
289. L Squires S Zola-Morgan 1991 The medial temporal lobe memory system Science 253 1380 1386 10.1126/science.1896849 (Pubitemid 21917285)
290. GT Stebbins CM Murphy 2009 Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment Behav Neurol 21 39 49 1:STN:280: DC%2BD1Mjgslektw%3D%3D 19847044
291. Stoub TR, Rogalski EJ, Leurgans S, Bennett DA, Detoledo-Morrell L (2008) Rate of entorhinal and hippocampal atrophy in incipient and mild AD: Relation to memory function. Neurobiol Aging, 2008 Sep 20
292. WJ Streit H Braak QS Xue I Bechmann 2009 Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease Acta Neuropathol 118 475 485 19513731 10.1007/s00401-009-0556-6
293. N Striepens L Scheef A Wind J Popp A Spottke D Cooper-Mahkorn H Suliman M Wagner HH Schild F Jessen 2010 Volume loss of the medial temporal lobe structures in subjective memory impairment Dement Geriatr Cogn Disord 29 75 81 20110703 10.1159/000264630
294. K Sugaya 2008 Mechanism of glial differentiation of neural progenitor cells by amyloid precursor protein Neurodegener Dis 5 170 172 1:CAS:528:DC%2BD1cXjs1Wht7k%3D 18322381 10.1159/000113693 (Pubitemid 351347841)
295. K Sugaya A Alvarez A Marutle YD Kwak E Choumkina 2006 Stem cell strategies for Alzheimer's disease therapy Panminerva Med 48 87 96 1:STN:280:DC%2BD28rivVymtA%3D%3D 16953146 (Pubitemid 44671264)
296. K Sugaya YD Kwak O Ohmitsu A Marutle NH Greig E Choumrina 2007 Practical issues in stem cell therapy for Alzheimer's disease Curr Alzheimer Res 4 370 377 1:CAS:528:DC%2BD2sXhtlSitL7L 17908039 10.2174/156720507781788936 (Pubitemid 47416630)
297. D Sulzer 2007 Multiple hit hypotheses for dopamine neuron loss in parkinson's disease Trends Neurosci 30 244 250 1:CAS:528:DC%2BD2sXkslent7g%3D 17418429 10.1016/j.tins.2007.03.009 (Pubitemid 46667168)
298. MH Tabert X Liu RL Doty M Serby D Zamora GH Pelton K Marder MW Albers Y Stern DP Devanand 2005 A 10-item smell identification scale related to risk for Alzheimer's disease Ann Neurol 58 155 160 15984022 10.1002/ana.20533 (Pubitemid 40962473)
299. CC Tang KL Poston V Dhawan D Eidelberg 2010 Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease J Neurosci 30 1049 1056 1:CAS:528:DC%2BC3cXhtlKmurc%3D 20089913 10.1523/JNEUROSCI.4188-09.2010
300. SJ Teipel R Stahl O Dietrich SO Schoenberg R Perneczky AL Bokde MF Reiser HJ Moller H Hampel 2007 Multivariate network analysis of fiber tract integrity in Alzheimer's disease NeuroImage 34 985 995 17166745 10.1016/j.neuroimage.2006. 07.047
301. E Terriere M Sharman C Donaghey L Herrmann J Lonie M Strachan N Dougall J Best K Ebmeier S Pimlott J Patterson D Wyper 2008 Alpha-4-beta-2-nicotinic receptor binding with 5-1A in Alzheimer's disease: methods of scan analysis Neurochem Res 33 643 651 1:CAS:528:DC%2BD1cXislyqsbo%3D 17960479 10.1007/s11064-007-9517-4 (Pubitemid 351341637)
302. Terriere E, Dempsey M, Herrmann L, Tierney K, Lonie J, O'Carroll R, Pimlott S, Wyper D, Herholz K, Ebmeier K (2009) 5-(123)I-A-85380 binding to the alpha-4-beta-2-nicotinic receptor in mild cognitive impairment. Neurobiol Aging, PMID: 19036475
303. RD Terry A Peck R DeTeresa 1981 Some morphometric aspects of the brain in senile dementia of Alzheimer's type Ann Neurol 10 184 192 1:STN:280: DyaL38%2Fit1ejtg%3D%3D 7283403 10.1002/ana.410100209 (Pubitemid 11053105)
304. PM Thompson KM Hayashi G de Zubicaray AL Janke SE Rose J Semple D Herman MS Hong SS Dittmer DM Doddrell AW Toga 2003 Dynamics of grey matter loss in Alzheimer's disease J Neurosci 23 994 1005 1:CAS:528:DC%2BD3sXhtlOrt7Y%3D 12574429 (Pubitemid 36206191)
305. VN Uversky 2009 Intrinsic disorder in proteins associated with neurodegenerative diseases Front Biosci 14 5188 5238 19482612 10.2741/3594
306. VN Uversky D Eliezer 2009 Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein Curr Protein Pept Sci 10 483 499 1:CAS:528:DC%2BD1MXhtlSit7jE 19538146 10.2174/138920309789351921
307. JJ van Hilten AD van der Zwan AH Zwinderman RA Roos 1994 Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale Mov Disord 9 84 88 8139609 10.1002/mds. 870090113 (Pubitemid 24022619)
308. P Vemuri JL Whitwell K Kantarci KA Josephs JE Parisi MS Shiung DS Knopman BF Boeve RC Petersen DW Dickson CR Jack Jr 2008 Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage Neuroimage 42 559 567 18572417 10.1016/j. neuroimage.2008.05.012
309. N Villain B Desgranges F Viader V de la Sayette F Mezenge B Landeau JC Baron F Eustache G Chetelat 2008 Relations between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease J Neurosci 28 6174 6181 1:CAS:528:DC%2BD1cXns1ygu7k%3D 18550759 10.1523/JNEUROSCI.1392-08.2008
310. C Volpato M Signorini F Meneghello C Semenza 2009 Cognitive and personality features in Parkinson disease: 2 sides of the same coin? Cogn Behav Neurol 22 258 263 19996879 10.1097/WNN.0b013e3181c12c63
311. PM Wadia AE Lang 2007 The many faces of corticobasal degeneration Parkinsonism Rel Disord 13 S336 S340 10.1016/S1353-8020(08)70027-0 (Pubitemid 351215265)
312. K Wakabayashi H Takahashi 1997 Neuropathology of autonomic nervous system in Parkinson's disease Eur Neurol 38 Suppl 2 2 7 9387796 10.1159/000113469 (Pubitemid 27453771)
313. K Wakabayashi F Mori H Takahashi 2006 Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease Parkinsonism Relat Disorder 12 92 98 10.1016/j.parkreldis.2006.05.028 (Pubitemid 44466466)
314. K Wakabayashi K Tanji F Mori H Takahashi 2007 The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of α-synuclein aggregates Neuropathology 27 494 506 18018486 10.1111/j.1440-1789.2007.00803.x (Pubitemid 47459715)
315. Y Wakisaka A Furuta Y Tanizaki Y Kiyohara M Iida T Iwaki 2003 Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study Acta Neuropathol 106 374 382 12904992 10.1007/s00401-003-0750-x (Pubitemid 37265318)
316. L Wang Y Zang Y He M Liang X Zhang L Tian Y Wu T Jiang K Li 2006 Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state MRI NeuroImage 31 496 504 16473024 10.1016/j.neuroimage. 2005.12.033 (Pubitemid 43776683)
317. L Wang MP Harms JM Staggs C Xiong JC Morris JG Csernansky JE Galvin 2010 Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease Arch Neurol 67 99 106 20065136 10.1001/archneurol.2009.292
318. KE Watkins T Paus JP Lerch A Zijdenbos DL Collins P Neelin J Taylor KJ Worsley AC Evans 2001 Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans Cereb Cortex 11 868 877 1:STN:280:DC%2BD3MvovF2qsA%3D%3D 11532891 10.1093/cercor/11.9.868 (Pubitemid 32800553)
319. R Watson AM Blamire JT O'Brien 2009 Magnetic resonance imaging in Lewy body dementias Dement Geriatr Cogn Disord 28 493 506 19996594 10.1159/000264614
320. MJ West PD Coleman DG Flood JC Troncoso 1994 Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease Lancet 344 769 772 1:STN:280:DyaK2czms1WqsQ%3D%3D 7916070 10.1016/S0140-6736(94)92338-8 (Pubitemid 24283954)
321. Whitwell JL (2010) Progression of atrophy in Alzheimer's disease and related disorder. Neurotoxicity Res (in press), PMID: 20352396
322. JL Whitwell SA Przybelski SD Weigand DS Knopman BF Boeve RC Petersen CR Jack Jr 2007 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain 130 1777 1786 17533169 10.1093/brain/awm112 (Pubitemid 47343806)
323. JL Whitwell KA Josephs ME Murray K Kantarci SA Przybelski SD Weigand P Vemuri ML Senjem JE Parisi DS Knopman BF Boeve RC Petersen DW Dickson CR Jack Jr 2008 MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study Neurology 71 743 749 1:STN:280: DC%2BD1crnslCgsA%3D%3D 18765650 10.1212/01.wnl.0000324924.91351.7d
324. JL Whitwell SA Przybelski SD Weigand RJ Ivnik P Vemuri JL Gunter ML Senjem MM Shiung BF Boeve DS Knopman JE Parisi DW Dickson RC Petersen CR Jack Jr KA Josephs 2009 Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study Brain 132 2932 2946 19762452 10.1093/brain/awp232
325. B Winblad K Palmer M Kivipelto V Jelic L Fratiglioni LO Wahlund A Nordberg L Bäckman M Albert O Almkvist H Arai H Basun K Blennow M de Leon C DeCarli T Erkinjuntti E Giacobini C Graff J Hardy C Jack A Jorm K Ritchie C van Duijn P Visser RC Petersen 2004 Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment J Intern Med 256 240 246 1:STN:280:DC%2BD2cvhvFCrsQ%3D%3D 15324367 10.1111/j.1365-2796.2004.01380.x (Pubitemid 39222993)
326. L Wolman S Roy 1969 The substantia nigra in Parkinsonism J Clin Pathol 22 507 508 1:STN:280:DyaF1M3ltFGlsg%3D%3D 5798646 10.1136/jcp.22.4.507-d
327. EC Wolters 2009 Non-motor extranigral signs and symptoms in Parkinson's disease Parkinsonism Relat Disord 15 Suppl 3 S6 S12 20083010 10.1016/S1353-8020(09)70770-9
328. EC Wolters C Francot P Bergmans A Winogrodzka J Booij HW Berendse JC Stoof 2000 Preclinical (premotor) Parkinson's disease J Neurol 247 103 109 (Pubitemid 30224313)
329. JL Woodard M Seidenberg KA Nielson P Antuono L Guidotti S Durgerian Q Zhang M Lancaster N Hantke A Butts SM Rao 2009 Semantic memory activation in amnestic mild cognitive impairment Brain 132 2068 2078 1:STN:280: DC%2BD1MrgtFSiuw%3D%3D 19515831 10.1093/brain/awp157
330. W Wu SA Small 2006 Imaging the earliest stages of Alzheimer's disease Curr Alzheimer Res 3 529 539 1:CAS:528:DC%2BD28XhtlWksbrE 17168652 10.2174/156720506779025161 (Pubitemid 46070117)
331. W Wu AM Brickman J Luchsinger P Ferrazzano P Pichiule M Yoshita T Brown C DeCarli CA Barnes R Mayeux SJ Vannucci SA Small 2008 The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life Ann Neurol 64 698 706 19107993 10.1002/ana.21557
332. S Xie JX Xiao GL Gong YF Zang YH Wang HK Wu XX Jiang 2006 Voxel-based detection of white matter abnormalities in mild Alzheimer disease Neurology 66 1845 1849 1:STN:280:DC%2BD28zosFKjsw%3D%3D 16801648 10.1212/01.wnl.0000219625. 77625.aa (Pubitemid 44049814)
333. JH Xuereb C Brayne C Dufouil H Gertz C Wischik C Harrington E Mukaetova-Ladinska MA McGee A O'Sullivan D O'Connor ES Paykel FA Huppert 2000 Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders Ann N Y Acad Sci 903 490 496 1:STN:280:DC%2BD3c3nvVCrtg%3D%3D 10818543 10.1111/j.1749-6632.2000. tb06404.x (Pubitemid 30251594)
334. R Yamamoto E Iseki W Marui T Togo O Katsuse M Kato D Isojima H Akatsu K Kosaka H Arai 2005 Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies Neuropathology 25 188 194 16193834 10.1111/j.1440-1789.2005.00627.x (Pubitemid 41602602)
335. KM Yazici Ö Kapucu B Erbas E Varoglu C Gülec CF Bekdik 1992 Assessment of changes in regional cerebral blood flow in patients with depression using the 99m Tc HMPAO single photon emission tomography method Eur J Nucl Med 19 1038 1043 1:STN:280:DyaK3s%2FpvF2hsg%3D%3D 1464356 10.1007/BF00180865 (Pubitemid 23003787)
336. GG Yener Turkuaz Alzheimer Working (TAC) Group 2009 The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey Cogn Behav Neurol 22 264 269 19996880 10.1097/WNN.0b013e3181c14737
337. J Zaccai P Ince C Brayne 2006 Population-based neuropathological studies of dementia: design, methods and areas of investigation-a systematic review BMC Neurol 9 2 10.1186/1471-2377-6-2 (Pubitemid 43103500)
338. J Zaccai C Brayne I McKeith F Matthews PG Ince MRC Cognitive Function Ageing Neuropathology Study 2008 Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort Neurology 70 1042 1048 1:CAS:528:DC%2BD1cXjs1Kjtrk%3D 18362284 10.1212/01.wnl.0000306697.48738.b6 (Pubitemid 351451312)
339. Zerboni L, Sobel RA, Ramachandran V, Rajamani J, Ruyechan W, Abendroth A, Arvin A (2010) The expression of varicella-zoster virus immediate early regulatory protein IE63 in neurons of latently infected human sensory ganglia. J Virol 84:3421-3430
340. Y Zhang N Schuff GH Jahng W Bayne S Mori L Schad S Mueller AT Du JH Kramer K Yaffe H Chui WJ Jagust BL Miller MW Weiner 2007 Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease Neurology 68 13 19 1:STN:280:DC%2BD2s%2FgsV2hsA%3D%3D 17200485 10.1212/01.wnl.0000250326.77323.01 (Pubitemid 46058544)
341. XW Zhou X Li C Bjorkdahl MJ Sjogren I Alafuzoff H Soininen I Grundke-Iqbal K Iqbal B Winblad JJ Pei 2006 Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains Neurobiol Dis 22 657 668 1:CAS:528:DC%2BD28Xls1aksrs%3D 16513361 10.1016/j.nbd.2006.01.006 (Pubitemid 43832136)